Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,127 $ 1,090
Accounts receivable and contract assets, net of allowance for credit losses of $28 million and $21 million, respectively 243 192
Income taxes receivable 46 3
Other current assets 62 39
Total current assets 1,478 1,324
Property and equipment, net 81 87
Intangible assets not subject to amortization:    
Goodwill 1,392 1,387
Trademarks 525 522
Intangible assets not subject to amortization 1,917 1,909
Intangible assets subject to amortization, net 122 116
Other assets 145 124
Total assets 3,743 3,560
Current liabilities:    
Deferred merchant and other payables 423 265
Current portion of debt, including $309 million measured at fair value as of September 30, 2024 314  
Deferred revenue 61 49
Series A Preferred Stock liability (note 6) 265  
Accrued liabilities and other current liabilities 306 262
Total current liabilities 1,369 576
Long-term debt, including $0 and $287 million measured at fair value as of September 30, 2024 and December 31, 2023, respectively (note 5) 886 1,180
Deferred income tax liabilities 31 49
Financial instrument liabilities (note 4)   21
Series A Preferred Stock liability (note 6)   249
Other liabilities 163 253
Total liabilities 2,449 2,328
Equity    
Additional paid-in capital 304 307
Accumulated other comprehensive earnings (loss), net of taxes   (2)
Retained earnings (deficit) (737) (724)
Total stockholders' equity (432) (418)
Noncontrolling interests in equity of subsidiaries 1,726 1,650
Total equity 1,294 1,232
Commitments and contingencies (note 8)
Total liabilities and equity 3,743 3,560
Series A    
Equity    
Common stock value 1 1
Series B    
Equity    
Common stock value
Series C    
Equity    
Common stock value